Viewing Study NCT06572930



Ignite Creation Date: 2024-10-26 @ 3:38 PM
Last Modification Date: 2024-10-26 @ 3:38 PM
Study NCT ID: NCT06572930
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-08-08

Brief Title: Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
Sponsor: None
Organization: None

Study Overview

Official Title: Assessment of the Role of Serum FSH Monitoring During Ovarian Stimulation and Identification of an Optimal Range for Expected Normal Responders
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FSH
Brief Summary: This study examines if monitoring serum Follicle Stimulation Hormone FSH levels can predict oocyte yield and progesterone levels considering factors like age baseline FSH Antral Mullerian Hormone AMH antral follicle count body weight kidney function and urinary FSH The aim is to find a minimum FSH level that ensures optimal ovarian response and enables tailored FSH dosages for better outcomes
Detailed Description: Ovarian stimulation typically uses transvaginal ultrasound to monitor follicle growth and endometrial condition with some clinics also tracking serum estradiol and progesterone levels but often neglecting serum Follicle Stimulation Hormone FSH FSH is essential for follicle development yet its levels can vary widely among women receiving the same dose due to factors like body weight renal function and ovarian reserve

This study aims to identify a minimum effective FSH threshold that ensures optimal follicular growth while avoiding excess administration

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None